StevenArnoldMD

Neurodegenerative, Dementia & Geriatrics

Faculty of the Department of Neurology at Massachusetts General Hospital as Translational Neurology Head of the Interdisciplinary Brain Center

Dr. Arnold is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Steven Arnold is a neurologist and psychiatrist in Boston, MA and is affiliated with Massachusetts General Hospital. He received his medical degree from Boston University School of Medicine and has been in practice 33 years. He specializes in neurodegenerative diseases and dementia & and is experienced in alzheimer's disease, behavioral neurology / neuropsychiatry, and geriatrics / dementia.

University of Iowa Hospitals and ClinicsResidency, Neurology, 1987 - 1990
New York Presbyterian Hospital (Columbia Campus)/New York State Psychiatric InstituteResidency, Psychiatry, 1984 - 1987
Icahn School of Medicine at Mount Sinai/Morningside/WestInternship, Internal Medicine, 1983 - 1984
Boston University School of MedicineClass of 1983

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

PubMed

132 citations
Transethnic genome-wide scan identifies novel Alzheimer's disease loci
Gyungah Jun, Jaeyoon Chung, Jesse Mez, Robert Barber, Gary W. Beecham
Alzheimer's & Dementia. 2017-07-01
194 citations
A novel Alzheimer disease locus located near the gene encoding tau protein
Gyungah Jun, Carla A. Ibrahim-Verbaas, Maria Vronskaya, J-C Lambert, Jaeyoon Chung
Molecular Psychiatry. 2016-01-01
1427 citations
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.
Adam C. Naj, Gyungah Jun, Gary W. Beecham, Li-San Wang, Badri N. Vardarajan
Nature Genetics. 2011-05-01

Journal Articles

Neurodegenerative Disease Concomitant Proteinopathies Are Prevalent, Age-Related and APOE4-Associated
David Wolk, Steven E Arnold, Edward B Lee, David J Irwin, Leo McCluskey, Howard I Hurtig, Lauren Elman, Bruce Miller, Murray Grossman, John E Duda, John Q Trojanowski,..., Brain

Amylyx Touts ‘Encouraging’ Phase 2 Alzheimer’s Trial DataAugust 15th, 2024
Amylyx Pharmaceuticals Announces Publication of Data Showing the Encouraging Effects of AMX0035 on Cerebrospinal Fluid Biomarkers of Core Alzheimer’s Disease Pathology and NeurodegenerationAugust 12th, 2024
Inside the Hunt for an Alzheimer’s Disease VaccineDecember 16th, 2022
Join now to see all

Targeted Proteomics Of Resilient Cognition In AgingNational Institute On Aging2011–2012
Neurobiology Of Dysbindin In Schizophrenia And Sdy MouseNational Institute Of Mental Health2005–2008
Plasticity In Stimulus Encoding Circuits In SchizophreniaNational Institute Of Mental Health2001–2002
Olfactory Neurodevelopmental Pathology In SchizophreniaNational Institute Of Mental Health2000–2002
MAP2 And The Neuronal Cytoskeleton In SchizophreniaNational Institute Of Mental Health1999–2002
Clinical Research Education In Mental HealthNational Institute Of Mental Health2001
Neuropathology Of Dementia In Elderly SchizophrenicsNational Institute Of Mental Health1995–1999
Molecular Neuroanatomy Of SchizophreniaNational Institute Of Mental Health1992–1996